Unknown

Dataset Information

0

Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells.


ABSTRACT: Cell based assessment tools and screening platforms are the preferred paradigm for small molecule identification and validation due to selectively identifying molecules with cellular activity and validation of compound activity against target proteins in their native environment. With respect to Regulator of G Protein Signaling (RGS) proteins, current cell based methodologies are either low throughput or monitor downstream signaling consequences. The increasing number of reports indicating RGS function in various disease pathogeneses highlights the need for a robust RGS inhibitor discovery and characterization paradigm. Promega's NanoBit Protein Complementation Assay utilizes NanoLuc, an engineered luciferase with enhanced luminescence characteristics which allow for both robust and kinetic assessment of protein interaction formation and disruption. Here we characterized 15 separate RGS: G protein interactions using this system. The binding profile of RGS: G? interactions correlates to prior published biochemical binding profiles of these proteins. Additionally, we demonstrated this system is suitable for high throughput screening efforts via calculation of Z-factors for three of the interactions and demonstrated that a known small molecule inhibitor of RGS4 disrupts the RGS4: G?i1 protein-protein interaction. In conclusion, the NanoBit Protein Complementation Assay holds promise as a robust platform for discovery and characterization of RGS inhibitors.

SUBMITTER: Bodle CR 

PROVIDER: S-EPMC5330260 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells.

Bodle Christopher R CR   Hayes Michael P MP   O'Brien Joseph B JB   Roman David L DL  

Analytical biochemistry 20170120


Cell based assessment tools and screening platforms are the preferred paradigm for small molecule identification and validation due to selectively identifying molecules with cellular activity and validation of compound activity against target proteins in their native environment. With respect to Regulator of G Protein Signaling (RGS) proteins, current cell based methodologies are either low throughput or monitor downstream signaling consequences. The increasing number of reports indicating RGS f  ...[more]

Similar Datasets

| S-EPMC3189979 | biostudies-literature
| S-EPMC3041725 | biostudies-literature
| S-EPMC7031294 | biostudies-literature
| S-EPMC4629423 | biostudies-literature
| S-EPMC2570267 | biostudies-literature
| S-EPMC8478939 | biostudies-literature
| S-EPMC8054679 | biostudies-literature
| S-EPMC4932868 | biostudies-literature
| S-EPMC4973907 | biostudies-literature
| S-EPMC4070983 | biostudies-literature